Loading stock data...

Prevest Denpro Limited

BSE: PREVEST

BSE
445.75 -21.25 (-4.55%)

Prev Close

467

Open Price

455.2

Volume

6,600

Today Low / High

443.2 / 460

52 WK Low / High

393.6 / 622.05

Range

423 - 468

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 445.75, reflecting a change of -21.25 (-4.55032%). The expected target range on the BSE is 423 - 468. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

23 Feb 465.05 0.42%
20 Feb 470.00 2.13%
19 Feb 464.90 0.44%
18 Feb 459.85 -0.49%
17 Feb 440.20 2.56%
16 Feb 448.00 2.34%
13 Feb 433.50 3.90%
12 Feb 479.85 -3.90%
11 Feb 457.00 4.26%
10 Feb 455.00 0.02%
09 Feb 445.05 2.37%
06 Feb 440.00 3.41%
05 Feb 457.00 -2.13%
04 Feb 469.90 -2.73%
03 Feb 442.00 2.49%
02 Feb 440.05 -1.26%
01 Feb 443.80 -1.30%
30 Jan 450.00 -2.78%
29 Jan 455.00 -1.20%
28 Jan 452.20 1.28%

Prevest Denpro Limited Graph

Prevest Denpro Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Prevest Denpro Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 445.75, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 445.75 450.21 405.19 - 495.23
454.67 363.73 - 545.60
459.12 321.39 - 596.86
Bearish Scenario 445.75 441.29 397.16 - 485.42
436.84 349.47 - 524.20
432.38 302.66 - 562.09

Overview of Prevest Denpro Limited

ISIN

INE0GAO01018

Industry

Medical - Specialties

Vol.Avg

6,742

Market Cap

5,605,401,000

Last Dividend

1

Official Website

Visit Website

IPO Date

2021-09-23

DCF Diff

-95.57

DCF

563

Financial Ratios Every Investor Needs

Stock Dividend of PREVEST

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-09-03 September 03, 25 1 1 2025-09-03 2025-10-09
2024-08-30 August 30, 24 1 1 2024-08-30 2024-10-06
2023-08-23 August 23, 23 1 1 2023-08-23 2023-09-29

Stock Rating Details for PREVEST

Metric Value Recommendation
Overall Rating C Sell
DCF Score 4 Buy
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 63.03 Cr 12.25 Cr 50.78 Cr 0.8056 0.00 Cr 1.51 Cr 20.18 Cr 18.16 Cr 15.12 26.15 Cr 0.2880
2024-03-31 56.43 Cr 21.15 Cr 42.35 Cr 0.7506 0.06 Cr 1.41 Cr 18.78 Cr 16.14 Cr 13.45 22.92 Cr 0.2860
2023-03-31 49.85 Cr 19.06 Cr 30.80 Cr 0.6178 0.01 Cr 1.03 Cr 19.39 Cr 15.71 Cr 13.09 21.84 Cr 0.3151
2022-03-31 38.11 Cr 9.78 Cr 28.33 Cr 0.7434 0.01 Cr 1.03 Cr 14.70 Cr 11.57 Cr 9.64 16.84 Cr 0.3036
2021-03-31 27.44 Cr 12.21 Cr 15.23 Cr 0.5550 0.16 Cr 6.51 Cr 8.57 Cr 7.21 Cr 8.16 10.06 Cr 0.2626

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 60.90 Cr 112.53 Cr 6.96 Cr 105.5718 Cr 0.00 Cr -60.90 Cr 8.04 Cr 26.81 Cr 0.00 Cr 0.00 Cr 0.00 Cr 5.9617 Cr
2024-03-31 48.61 Cr 94.82 Cr 6.20 Cr 88.6175 Cr 0.00 Cr -48.61 Cr 6.24 Cr 26.75 Cr 0.32 Cr 0.00 Cr 0.00 Cr 5.5114 Cr
2023-03-31 39.00 Cr 78.61 Cr 5.81 Cr 72.7975 Cr 0.00 Cr -39.00 Cr 6.08 Cr 24.29 Cr 1.05 Cr 0.00 Cr 0.00 Cr 5.4404 Cr
2022-03-31 42.32 Cr 64.14 Cr 7.05 Cr 57.0874 Cr 1.37 Cr -40.95 Cr 5.76 Cr 11.44 Cr 0.84 Cr 0.00 Cr 0.00 Cr 5.3994 Cr
2021-03-31 16.42 Cr 30.68 Cr 8.18 Cr 22.4960 Cr 1.39 Cr -15.03 Cr 1.96 Cr 7.07 Cr 0.00 Cr 0.00 Cr 0.00 Cr 6.5464 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 14.8174 Cr -1.3290 Cr -1.2003 Cr 12.8491 Cr 12.2881 Cr 60.8984 Cr -1.9683 Cr 24.2497 Cr 0.0000 Cr -1.2003 Cr -1.7946 Cr
2024-03-31 11.6248 Cr -1.7008 Cr -0.3168 Cr 7.8934 Cr 9.6072 Cr 48.6103 Cr -3.7314 Cr 16.1369 Cr 0.0000 Cr -0.3168 Cr -1.4515 Cr
2023-03-31 10.6671 Cr -12.3772 Cr -1.3667 Cr -2.8606 Cr -3.3333 Cr 39.0031 Cr -13.5277 Cr 15.7101 Cr -1.3667 Cr 0.0000 Cr -1.5252 Cr
2022-03-31 6.9623 Cr -3.8657 Cr 22.8182 Cr 3.2834 Cr 25.9147 Cr 42.3364 Cr -4.8909 Cr 11.5688 Cr -0.0272 Cr 0.0000 Cr -1.9905 Cr
2021-03-31 8.7563 Cr -1.9269 Cr -0.5689 Cr 6.5245 Cr 6.1258 Cr 16.4217 Cr -2.2318 Cr 7.2067 Cr -0.2508 Cr 0.0000 Cr -0.1428 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-12-31 18.46 Cr 7.73 Cr 10.73 Cr 0.5811 5.29 Cr 4.72 Cr 3.93 5.80 Cr 0.2557
2025-09-30 18.64 Cr 4.73 Cr 13.91 Cr 0.7460 6.18 Cr 5.54 Cr 4.62 7.87 Cr 0.2973
2025-06-30 15.77 Cr 3.56 Cr 12.21 Cr 0.7743 4.82 Cr 4.41 Cr 3.67 6.48 Cr 0.2794
2025-03-31 18.45 Cr 2.45 Cr 16.00 Cr 0.8670 6.08 Cr 5.14 Cr 4.28 7.62 Cr 0.2786
2024-12-31 14.95 Cr 3.28 Cr 11.67 Cr 0.7806 4.73 Cr 4.53 Cr 3.77 6.30 Cr 0.3028

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 67.49 Cr 6.22 Cr 73.71 Cr 11.50 Cr 9.20 Cr 96.54 Cr 26.40 Cr 123.05 Cr 7.53 Cr
2025-06-30 0.00 Cr 0.00 Cr 65.60 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -105.57 Cr
2025-03-31 60.90 Cr 4.70 Cr 65.60 Cr 9.77 Cr 8.04 Cr 85.72 Cr 26.81 Cr 112.53 Cr 6.96 Cr
2024-12-31 0.00 Cr 0.00 Cr 59.73 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -95.91 Cr
2024-09-30 55.95 Cr 3.78 Cr 59.73 Cr 7.88 Cr 6.71 Cr 76.23 Cr 26.44 Cr 102.67 Cr 6.76 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 4.41 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 5.14 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 4.53 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 4.82 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 3.67 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Specialties

No stocks found in this industry.

Key Executives

Director of Research & Academics and Executive Director
Sai Kalyan Surapaneni

Gender: Not Specified

Year Born: 1978

Company Secretary & Compliance Officer
Aman Sadhotra

Gender: male

Year Born:

MD & Chairman
Atul Modi

Gender: male

Year Born: 1953

CMO & Executive Director
Vaibhav Munjal

Gender: male

Year Born:

Financial Adviser
Vinay Jamwal

Gender: male

Year Born:

Chief Financial Officer & Whole Time Director
Namrata Modi

Gender: female

Year Born: 1958

FAQs about Prevest Denpro Limited

Who is the CEO of the company?

The CEO is Atul Modi.

What is the current market price of the stock?

The current price is ₹467.00.

What is the 52-week price range?

The range is ₹393.6-622.05.

What is the market capitalization of the company?

The market capitalization is ₹560.54 crores.

What is the dividend yield?

The dividend yield is 0.21%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 28.30.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Prevest Denpro Limited (ISIN: INE0GAO01018) is a leading Medical - Specialties in India. With a market capitalization of ₹560.54 crores and an average daily volume of 6,742 shares, it operates in the Medical - Specialties. The company last declared a dividend of ₹1.